Ngambenjawong C[au] - Search Results

Year	Number of Results
2015	1
2016	3
2017	3
2018	2
2021	1
2022	1
2023	1
2024	0

1

Progress in tumor-associated macrophage (TAM)-targeted therapeutics.

Ngambenjawong C, Gustafson HH, Pun SH. Ngambenjawong C, et al. Adv Drug Deliv Rev. 2017 May 15;114:206-221. doi: 10.1016/j.addr.2017.04.010. Epub 2017 Apr 25. Adv Drug Deliv Rev. 2017. PMID: 28449873 Free PMC article. Review.

2

CRISPR-Cas-amplified urinary biomarkers for multiplexed and portable cancer diagnostics.

Hao L, Zhao RT, Welch NL, Tan EKW, Zhong Q, Harzallah NS, Ngambenjawong C, Ko H, Fleming HE, Sabeti PC, Bhatia SN. Hao L, et al. Among authors: ngambenjawong c. Nat Nanotechnol. 2023 Jul;18(7):798-807. doi: 10.1038/s41565-023-01372-9. Epub 2023 Apr 24. Nat Nanotechnol. 2023. PMID: 37095220 Free PMC article.

3

Conditional Antimicrobial Peptide Therapeutics.

Ngambenjawong C, Chan LW, Fleming HE, Bhatia SN. Ngambenjawong C, et al. ACS Nano. 2022 Oct 25;16(10):15779-15791. doi: 10.1021/acsnano.2c04162. Epub 2022 Aug 18. ACS Nano. 2022. PMID: 35980829 Free PMC article.

4

Selective Permeabilization of Gram-Negative Bacterial Membranes Using Multivalent Peptide Constructs for Antibiotic Sensitization.

Chan LW, Hern KE, Ngambenjawong C, Lee K, Kwon EJ, Hung DT, Bhatia SN. Chan LW, et al. Among authors: ngambenjawong c. ACS Infect Dis. 2021 Apr 9;7(4):721-732. doi: 10.1021/acsinfecdis.0c00805. Epub 2021 Mar 9. ACS Infect Dis. 2021. PMID: 33689277 Free PMC article.

5

Reversibly Switchable, pH-Dependent Peptide Ligand Binding via 3,5-Diiodotyrosine Substitutions.

Ngambenjawong C, Sylvestre M, Gustafson HH, Pineda JMB, Pun SH. Ngambenjawong C, et al. ACS Chem Biol. 2018 Apr 20;13(4):995-1002. doi: 10.1021/acschembio.8b00171. Epub 2018 Mar 5. ACS Chem Biol. 2018. PMID: 29481044

6

Glomerular disease augments kidney accumulation of synthetic anionic polymers.

Liu GW, Prossnitz AN, Eng DG, Cheng Y, Subrahmanyam N, Pippin JW, Lamm RJ, Ngambenjawong C, Ghandehari H, Shankland SJ, Pun SH. Liu GW, et al. Among authors: ngambenjawong c. Biomaterials. 2018 Sep;178:317-325. doi: 10.1016/j.biomaterials.2018.06.001. Epub 2018 Jun 2. Biomaterials. 2018. PMID: 29891232

7

A Facile Cyclization Method Improves Peptide Serum Stability and Confers Intrinsic Fluorescence.

Ngambenjawong C, Gustafson HH, Sylvestre M, Pun SH. Ngambenjawong C, et al. Chembiochem. 2017 Dec 14;18(24):2395-2398. doi: 10.1002/cbic.201700446. Epub 2017 Nov 7. Chembiochem. 2017. PMID: 29044914 Free PMC article.

8

Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity.

Chu DS, Bocek MJ, Shi J, Ta A, Ngambenjawong C, Rostomily RC, Pun SH. Chu DS, et al. Among authors: ngambenjawong c. J Control Release. 2015 May 10;205:155-61. doi: 10.1016/j.jconrel.2015.01.013. Epub 2015 Jan 14. J Control Release. 2015. PMID: 25596326 Free PMC article.

9

Engineering an Affinity-Enhanced Peptide through Optimization of Cyclization Chemistry.

Ngambenjawong C, Pineda JM, Pun SH. Ngambenjawong C, et al. Bioconjug Chem. 2016 Dec 21;27(12):2854-2862. doi: 10.1021/acs.bioconjchem.6b00502. Epub 2016 Nov 10. Bioconjug Chem. 2016. PMID: 27779387 Free PMC article.

10

Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep).

Ngambenjawong C, Gustafson HH, Pineda JM, Kacherovsky NA, Cieslewicz M, Pun SH. Ngambenjawong C, et al. Theranostics. 2016 Jun 15;6(9):1403-14. doi: 10.7150/thno.15394. eCollection 2016. Theranostics. 2016. PMID: 27375788 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year